BIO's 2017 Special 301 Submission

BIO submitted a report to the United States Trade Representative regarding the agency’s 2017 Special 301 Review.

BIO appreciates the opportunity to comment on the intellectual property rights issues affecting U.S. biotechnology companies abroad. We hope our contribution will assist the efforts in preserving strong intellectual property protections for United States’ companies internationally.